GSK
XNYSGSK PLC-SPON ADR
Avg. sentiment
0.60bullish
1 news · 90d
7d trend
0.60—
1 news · vs previous 7d (—)
Breakdown
↑ 1• 0↓ 0
Sentiment velocity
——/day
Acceleration —
Sentiment scores computed by AI · Not investment advice.
No price data available for this ticker.
Track $GSK sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 1
How did the price react? →- SeekingAlpha6/9/2026, 7:02:29 AMGSK to buy Nuvalent for $10.6B
GSK has announced a definitive agreement to acquire Nuvalent for $10.6 billion. The deal represents a significant expansion of GSK's oncology pipeline, targeting Nuvalent's portfolio of precision cancer therapies. No further terms or closing timeline were disclosed in the headline.